Allison Aubrey

Allison Aubrey is a correspondent for NPR News, where her stories can be heard on Morning Edition and All Things Considered. She's also a contributor to the PBS NewsHour and is one of the hosts of NPR's Life Kit.

Along with her NPR science desk colleagues, Aubrey is the winner of a 2019 Gracie Award. She is the recipient of a 2018 James Beard broadcast award for her coverage of 'Food As Medicine.' Aubrey is also a 2016 winner of a James Beard Award in the category of "Best TV Segment" for a PBS/NPR collaboration. The series of stories included an investigation of the link between pesticides and the decline of bees and other pollinators, and a two-part series on food waste. In 2013, Aubrey won a Gracie Award with her colleagues on The Salt, NPR's food vertical. They also won a 2012 James Beard Award for best food blog. In 2009, Aubrey was awarded the American Society for Nutrition's Media Award for her reporting on food and nutrition. She was honored with the 2006 National Press Club Award for Consumer Journalism in radio and earned a 2005 Medical Evidence Fellowship by the Massachusetts Institute of Technology and the Knight Foundation. In 2009-2010, she was a Kaiser Media Fellow.

Joining NPR in 2003 as a general assignment reporter, Aubrey spent five years covering environmental policy, as well as contributing to coverage of Washington, D.C., for NPR's National Desk. She also hosted NPR's Tiny Desk Kitchen video series.

Before coming to NPR, Aubrey was a reporter for the PBS NewsHour and a producer for C-SPAN's Presidential election coverage.

Aubrey received her Bachelor of Arts degree from Denison University in Granville, Ohio, and a Master of Arts degree from Georgetown University in Washington, D.C.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

STEVE INSKEEP, HOST:

In the early months of the vaccination campaign, Internet access was essential to the search for a vaccination appointment.

But given that more than 14 million people in the U.S. lack reliable access to high speed Internet, technology has been a barrier for some Americans.

The Centers for Disease Control and Prevention says people who are fully vaccinated do not need to wear a mask when they're outdoors unless they're in a crowd, such as attending a live performance, sporting event or parade. People are considered fully vaccinated two weeks after receiving the second dose of the Pfizer or Moderna vaccines, or two weeks after the single dose of the Johnson & Johnson shot.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

STEVE INSKEEP, HOST:

A political debate has erupted over the idea of requiring proof of COVID-19 vaccination for entry into certain settings. While politicians argue over equity and privacy concerns, some businesses and institutions are moving ahead and developing apps for people to prove their status easily and securely.

When students return to Cornell University for the fall semester, for example, they'll be required to be vaccinated with exemptions for medical or religious reasons.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

STEVE INSKEEP, HOST:

If you long to see loved ones or dip your toes in the sand, you're not alone.

It's been over a year since the pandemic locked down most of the U.S., and despite guidance from the Centers for Disease Control and Prevention to avoid nonessential travel, more Americans are now on the go — booking flights and planning vacations.

The Centers for Disease Control and Prevention has issued new guidance for vaccinated people, giving the green light to resume some pre-pandemic activities and relax precautions that have been in place.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

MARY LOUISE KELLY, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

NOEL KING, HOST:

COVID-19 vaccines are akin to liquid gold these days. As more people become eligible, the demand continues to outstrip current supply. And while states aim to manage their weekly allotments of the Pfizer and Moderna vaccines to ensure there are enough shots for second doses, there are scattered reports of snafus and postponed appointments.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

RACHEL MARTIN, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

NOEL KING, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

ARI SHAPIRO, HOST:

There are millions of people waiting eagerly, perhaps impatiently, for the chance to be vaccinated. But among those who have already been offered the shot, one group stands out for taking a pass. NPR's Allison Aubrey reports.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

STEVE INSKEEP, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

RACHEL MARTIN, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

NOEL KING, HOST:

Copyright 2020 NPR. To see more, visit https://www.npr.org.

LULU GARCIA-NAVARRO, HOST:

Updated at 6:49 a.m. ET

As coronavirus cases surge around the country, President-elect Joe Biden says voters have given him a mandate to take action.

"Daily cases are skyrocketing," Biden said in remarks Friday evening in Wilmington, Del., as the nation waited for the election to be called. "I want everyone — everyone — to know on Day 1, we're going to put our plan to control this virus into action."

As Election Day nears, the pandemic looms large. Amid a surge in new cases, the coronavirus has changed the way we live, work and — perhaps — how some Americans will vote.

As President Trump makes the case that his leadership has saved lives in the pandemic and ushered in record-fast vaccine and therapeutics development, Joe Biden has described Trump's handling of COVID-19 as "totally irresponsible" and points to American's health as the nation's top domestic issue.

Pfizer announced this week that it has received FDA approval to enroll children as young as 12 years old in its COVID-19 vaccine trial. The expansion is aimed at understanding whether the vaccine would be safe and effective for adolescents.

Until now, children under 16 have not been included in any of the COVID-19 vaccine trials in the U.S., and the average age of participants has skewed much older.

Copyright 2020 NPR. To see more, visit https://www.npr.org.

NOEL KING, HOST:

Copyright 2020 NPR. To see more, visit https://www.npr.org.

MICHEL MARTIN, HOST:

As we get closer to a COVID-19 vaccine, it's exciting to imagine a day when the virus is gone. But a vaccine will not be a magic bullet. In fact, it may be only about 50% effective.

Dr. Anthony Fauci, chief of the National Institute of Health and Infectious Disease, has tried to set realistic expectations when discussing the importance of a vaccine. "We don't know yet what the efficacy might be. We don't know if it will be 50% or 60%," Fauci said during a Brown University event in August.

Copyright 2020 NPR. To see more, visit https://www.npr.org.

NOEL KING, HOST:

Updated 4:10 p.m. ET

As students return to the campus of University of Illinois at Urbana-Champaign this month, they will be tested for COVID-19. And, then they'll be tested, again.

"We are requiring testing two times per week for access to campus facilities. This is for students, faculty, and staff," explains Rebecca Lee Smith, an associate professor of epidemiology.

Copyright 2020 NPR. To see more, visit https://www.npr.org.

STEVE INSKEEP, HOST:

Copyright 2020 NPR. To see more, visit https://www.npr.org.

STACEY VANEK SMITH, HOST:

As schools across the country grapple with bringing kids back into the classroom, parents — and teachers — are worried about safety. We asked pediatricians, infectious disease specialists and education experts for help evaluating school district plans.

What we learned: There's no such thing as zero risk, but certain practices can lower the risk of an outbreak at school and keep kids, teachers and families safer.

Pages